ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with KU Leuven covering CRISPR/Cas9 activities at the Leuven ...

Mapmygenome has completed its acquisition of Vancouver-based dnaPower, expanding its North American operations and adding capabilities across DNA testing, microbiome health, longevity, ...

For rural Mainers with cancer, advanced care once meant driving to Boston or traveling to an academic center. A decade in, the Jackson Laboratory’s Maine Cancer Genomics Initiative says it has flipped ...

Genomics is revolutionizing cancer treatment by allowing personalized care that reduces the amount of chemotherapy and ...

A stock compressed to a 10-year low price to earnings (PE) ratio rarely reflects a permanently broken business. It usually ...

Hologic Announces Agreement to Acquire Reveal Genomics to Expand Breast Cancer Genomic Testing / Breast Cancer Index test, ...

Hologic is acquiring precision oncology company Reveal Genomics. | Hologic is acquiring precision oncology company Reveal ...

Pacific Biosciences of California Inc. stocks have been trading up by 8.15 percent amid strong optimism over its genomic ...

Hologic signs deal to acquire Barcelona-based Reveal Genomics, expanding breast cancer diagnostics to complement its BCI test. Read the full deal details.

Paired-end sequencing now available on the UG200™ Series, advancing workflow compatibility and quality for germline whole ...

Genomics England research finds support for genomics, but concerns remain over data protection, fairness and NHS readiness.

PacBio and Verily Health will integrate HiFi long-read sequencing with health data and cloud tools to support biomedical ...